Eliminating roles for T-bet and IL-2 but revealing superior activation and proliferation as mechanisms underpinning dominance of regulatory T cells in tumors-Reference-Cited by-同舟云学术

Eliminating roles for T-bet and IL-2 but revealing superior activation and proliferation as mechanisms underpinning dominance of regulatory T cells in tumors

Published:2015-09-10 Issue:28 Volume:6 Page:24649-24659
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Colbeck Emily J.¹,Hindley James P.¹,Smart Kathryn¹,Jones Emma¹,Bloom Anja¹,Bridgeman Hayley¹,McPherson Rhoanne C.²,Turner Darryl G.²,Ladell Kristin¹,Price David A.¹,O’Connor Richard A.²,Anderton Stephen M.²,Godkin Andrew J.¹,Gallimore Awen M.¹

Affiliation:

1. Institute of Infection Immunity and Biochemistry, Cardiff University School of Medicine, Cardiff, UK

2. MRC Centre for Inflammation Research, Centre for Multiple Sclerosis Research and Centre for Immunity Infection and Evolution, University of Edinburgh, Edinburgh, UK

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stability and plasticity of regulatory T cells in health and disease;Journal of Leukocyte Biology;2024-03-01

2. A genetic method specifically delineates Th1-type Treg cells and their roles in tumor immunity;Cell Reports;2023-07

3. Using methylcholanthrene-induced fibrosarcomas to study tumor immunology;Methods in Cell Biology;2021

4. Enhanced antitumor immunity through sequential targeting of PI3Kδ and LAG3;Journal for ImmunoTherapy of Cancer;2020-10

5. Overproduction of IL-2 by Cbl-b deficient CD4+ T cells provides resistance against regulatory T cells;OncoImmunology;2020-01-01